MORTALITY PREDICTION IN PATIENTS WITH HBV-RELATED HEPATOCELLULAR CARCINOMA

被引：0
|
作者：
Ji, Dong [1 ]
Chen, Song-Hai [2 ]
Wang, Yu-Dong [3 ]
Lu, Yiying [2 ]
Chen, Guofeng [2 ]
Lau, George [3 ]
机构：
[1] Chinese Peoples Liberat Army Gen Hosp, Senior Dept Hepatol, Med Ctr 5, Beijing, Peoples R China
[2] Chinese Peoples Liberat Army Gen Hosp, Dept Liver Dis, Med Ctr 5, Beijing, Peoples R China
[3] Human & Hlth Med Grp, Beijing, Peoples R China
来源：
HEPATOLOGY | 2021年 / 74卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
719
引用
收藏
页码：439A / 439A
页数：1
相关论文
共 50 条
  • [1] Expression of Maspin in HBV-related Hepatocellular Carcinoma
    Moudi, Bita
    Mahmoudzadeh-Sagheb, Hamidreza
    Heidari, Zahra
    [J]. CLINICAL CANCER INVESTIGATION JOURNAL, 2019, 8 (01): : 1 - 6
  • [2] Deep learning model for prediction of hepatocellular carcinoma in patients with HBV-related cirrhosis on antiviral therapy
    Nam, Joon Yeul
    Sinn, Dong Hyun
    Bae, Junho
    Jang, Eun Sun
    Kim, Jin-Wook
    Jeong, Sook-Hyang
    [J]. JHEP REPORTS, 2020, 2 (06)
  • [3] Gene expression based recurrence prediction of HBV-related human hepatocellular carcinoma
    Kim, Yoon Jun
    Woo, Hyun Goo
    Jung, Yong Jin
    Kim, Dong Hee
    Park, Bum Joon
    Yi, Nam-Joon
    Suh, Kyung-Suk
    Lee, Kuhn Uk
    Yoon, Jung-Hwan
    Thorgeirsson, Snorri S.
    Lee, Hyo-Suk
    [J]. HEPATOLOGY, 2007, 46 (04) : 789A - 789A
  • [4] Serum Iron Levels Decreased in Patients with HBV-Related Hepatocellular Carcinoma, as a Risk Factor for the Prognosis of HBV-Related HCC
    Wei, Yanyan
    Ye, Wei
    Zhao, Wei
    [J]. FRONTIERS IN PHYSIOLOGY, 2018, 9
  • [5] Prognostic value of PUMA expression in patients with HBV-related hepatocellular carcinoma
    Berretta, M.
    Di Francia, R.
    Martella, L.
    Tirelli, U.
    [J]. European Review for Medical and Pharmacological Sciences, 2015, 19 (07) : 1117 - 1118
  • [6] Prognostic value of PUMA expression in patients with HBV-related hepatocellular carcinoma
    Peng, S. -L.
    Yao, D. -B.
    Zhao, Y.
    Xu, F.
    Jia, C. -J.
    Xu, Y. -Q.
    Dai, C. -L.
    [J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2015, 19 (01) : 38 - 44
  • [7] Serum soluble DR5 predicts mortality risk in patients with HBV-related hepatocellular carcinoma
    Liang, Jiaqi
    Feng, Ying
    Liu, Yao
    Shi, Ke
    Zhou, Guiqin
    Liu, Long
    Liu, Yaxin
    Qiao, Kexin
    Liu, Wen
    Wang, Xianbo
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
  • [8] The Role of Antiviral Therapy for HBV-Related Hepatocellular Carcinoma
    Yu, Liang-He
    Li, Nan
    Cheng, Shu-Qun
    [J]. INTERNATIONAL JOURNAL OF HEPATOLOGY, 2011, 2011
  • [9] Integrated Proteogenomic Characterization of HBV-Related Hepatocellular Carcinoma
    Gao, Qiang
    Zhu, Hongwen
    Dong, Liangqing
    Shi, Weiwei
    Chen, Ran
    Song, Zhijian
    Huang, Chen
    Li, Junqiang
    Dong, Xiaowei
    Zhou, Yanting
    Liu, Qian
    Ma, Lijie
    Wang, Xiaoying
    Zhou, Jian
    Liu, Yansheng
    Boja, Emily
    Robles, Ana I.
    Ma, Weiping
    Wang, Pei
    Li, Yize
    Ding, Li
    Wen, Bo
    Zhang, Bing
    Rodriguez, Henry
    Gao, Daming
    Zhou, Hu
    Fan, Jia
    [J]. CELL, 2019, 179 (02) : 561 - +
  • [10] Molecular and clinical characterization of HBV-related hepatocellular carcinoma
    Cao, Qian
    Amaddeo, Giuliana
    Ladeiro, Yannick
    Imbeaud, Sandrine
    Zucman-Rossi, Jessica
    [J]. HEPATOLOGY, 2013, 58 : 407A - 407A
12345